Testing effectiveness (Phase 2)Looking for participantsNCT05600920
What this trial is testing
A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 60